Periprocedural Management Of Antithrombotic Medications In Patients With Ischemic Cerebrovascular Disease

Authoring Organization

Publication Month/Year

May 27, 2013

Last Updated Month/Year

June 26, 2023

Supplemental Implementation Tools

Document Type


External Publication Status


Country of Publication


Document Objectives

To assess evidence regarding periprocedural management of antithrombotic drugs in patients with ischemic cerebrovascular disease. The complete guideline on which this summary is based is available as an online data supplement to this article.

Inclusion Criteria

Female, Male, Adult

Health Care Settings

Emergency care, Hospital, Operating and recovery room, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant


Prevention, Management

Diseases/Conditions (MeSH)

D002561 - Cerebrovascular Disorders


anticoagulation, antithrombotic, ischemic cerebrovascular disease, Anticoagulation

Source Citation

Summary of evidence-based guideline: Periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Melissa J. Armstrong, Gary Gronseth, David C. Anderson, José Biller, Brett Cucchiara, Rima Dafer, Larry B. Goldstein, Michael Schneck, Steven R. Messé. Neurology May 2013, 80 (22) 2065-2069; DOI: 10.1212/WNL.0b013e318294b32d

Supplemental Methodology Resources

Data Supplement, Data Supplement